glp-1 drugs news World Health Organization recommends for obesity GLP-1s like Ozempic are among

Does transdermal delivery actually work for berberine and chromium

What was once a relatively contained therapeutic class within endocrinology has expanded into a dual-purpose platform that operates across two distinct clinical domains

Drug classes to be on the lookout for are outlined in Table 2 , and include several major buckets: Incretins Plus : these assets often add additional agonism to the classic GLP-1 or GLP-1/GIP drugs

Scopoletin protects retinal ganglion cells 5 from high glucose-induced injury in a cellular model of diabetic retinopathy via ROS-dependent p38 and JNK signaling cascade

It joins a quickening race toward dosing intervals patients can actually live with

Although beneficiaries must be enrolled in Part D to participate, the short-term program will operate outside the Part D benefit for its duration from July 1 to December 31, 2026